Simeon George

Insider Reports History

Location
Conshohocken, PA
Signature
/s/ Sasha Keough, attorney-in-fact for Simeon George
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Simeon George:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Director Common Shares 1,730,179 $90,021,213 $52.03 16 Jul 2025 Indirect
Nkarta, Inc. Director Stock Option (right to buy) 46,000 05 Jun 2025 Direct
Design Therapeutics, Inc. Director, 10%+ Owner Stock Option (right to buy) 19,000 10 Jun 2025 Direct
CRISPR Therapeutics AG Director Stock Option (Right to Buy) 13,000 05 Jun 2025 Direct
Turning Point Therapeutics, Inc. Director Common Stock 0 $76.00 17 Aug 2022 Indirect
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 17 Aug 2022 Direct

Insider Reports Filed by Simeon George

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRSP CRISPR Therapeutics AG 16 Jul 2025 3 +$51,499,918 4 Director 17 Jul 2025, 17:19
DSGN Design Therapeutics, Inc. 10 Jun 2025 1 $0 4 Director, 10%+ Owner 12 Jun 2025, 16:48
NKTX Nkarta, Inc. 05 Jun 2025 1 $0 4 Director 09 Jun 2025, 16:39
CRSP CRISPR Therapeutics AG 05 Jun 2025 1 $0 4 Director 06 Jun 2025, 17:47
DSGN Design Therapeutics, Inc. 13 Jun 2024 1 $0 4 Director, 10%+ Owner 17 Jun 2024, 17:06
NKTX Nkarta, Inc. 13 Jun 2024 1 $0 4 Director 14 Jun 2024, 16:30
CRSP CRISPR Therapeutics AG 30 May 2024 1 $0 4 Director 31 May 2024, 16:50
NKTX Nkarta, Inc. 27 Mar 2024 2 +$20,000,000 4 Director 28 Mar 2024, 16:30
CRSP CRISPR Therapeutics AG 27 Feb 2024 3 +$74,999,996 4 Director 27 Feb 2024, 18:39
CRSP CRISPR Therapeutics AG 08 Jun 2023 1 $0 4 Director 09 Jun 2023, 17:56
NKTX Nkarta, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 17:42
DSGN Design Therapeutics, Inc. 31 May 2023 1 $0 4 Director, 10%+ Owner 02 Jun 2023, 16:48
DSGN Design Therapeutics, Inc. 16 Dec 2022 3 +$7,574,078 4 Director, 10%+ Owner 20 Dec 2022, 17:45
/report/000120919122046285-george-simeon-2022-08-17 Turning Point Therapeutics, Inc. 17 Aug 2022 4 -$171,278,160 4 Director 17 Aug 2022, 16:40
DSGN Design Therapeutics, Inc. 15 Jun 2022 1 $0 4 Director, 10%+ Owner 16 Jun 2022, 17:07
CRSP CRISPR Therapeutics AG 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 17:39
NKTX Nkarta, Inc. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:07
NKTX Nkarta, Inc. 28 Apr 2022 2 +$19,999,995 4 Director 29 Apr 2022, 16:27
NKTX Nkarta, Inc. 13 Jun 2021 1 $0 4 Director 15 Jun 2021, 10:29
CRSP CRISPR Therapeutics AG 10 Jun 2021 1 $0 4 Director 14 Jun 2021, 17:37
/report/000120919121038336-george-simeon-2021-06-02 Turning Point Therapeutics, Inc. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:44